The union for managers and professionals in public service
Home  >  News and media  >  News  >  Gender pay gap shows women are among those bearing the brunt of a broken civil service pay system, says FDA
Friday 01 December 2023

Gender pay gap shows women are among those bearing the brunt of a broken civil service pay system, says FDA

Prostock-studio via Shutterstock
A number of civil service departments have released their annual gender pay gap reports for 2023, all of which show a clear gap between the earnings of men and women. In response, FDA Assistant General Secretary Lucille Thirlby said:

“With median salaries at each grade falling in real terms by between 12% and 23% since 2010, civil service pay is broken and today’s gender pay gap figures show women are among those bearing the brunt of this. The civil service needs to grasp the nettle and urgently reform its pay systems, and reducing the gender pay gap should be a priority for every civil service employer.”

Several departments, including the Cabinet Office, Home Office, Department for Levelling Up, Communities and Housing, Department for Transport and Department of Health and Social Care even reported an increase in their pay gap. Thirlby stressed the importance of properly resourcing departments in order to eradicate this imbalance:
“Civil service HR professionals who specialise in EDI are vital to helping employers action change to reduce their gender pay gap. The Autumn Statement announcement around considering ‘streamlining equality, diversity and inclusion (EDI) training and HR processes’ in the civil service shows what little value this Government places on these issues.”

13th Jun 2024
If you are from a disadvantaged background, it is clear that becoming a member of a trade union, and particularly the FDA, improves your chances of getting in and getting on.
20th Nov 2023
Scott Dobson reports on the FDA's historic win on Fast Stream pay.
Find us
FDA, Centenary House, 93-95 Borough High Street, London, SE1 1NL                      
Copyright © 2024 FDA